Eberhard Gunsilius

Blood levels of vascular endothelial growth factor in obstructive sleep apnea-hypopnea syndrome.

Bone marrow-derived endothelial cells for therapeutic angiogenesis and antiangiogenesis: facts and visions.

Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer.

Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation.

Defective DNA-mismatch repair: a potential mediator of leukemogenic susceptibility in therapy-related myelodysplasia and leukemia.

High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration.

Low concentrations of STI571 in the cerebrospinal fluid: a case report.

Breaking the rules? X-ray examination of hematopoietic stem cell grafts at international airports.

In vivo release of vascular endothelial growth factor from colorectal carcinomas.

In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation.

Increase of regulatory T cells in the peripheral blood of cancer patients.

Evidence from a leukemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells.

Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells.

Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab.

Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation.

Expansion of mobilized peripheral blood progenitor cells under defined culture conditions rsing CD34+CD71-CD45- cells as a starting population.

Natural killer cell functions mediated by the neuropeptide substance P.

Hematopoietic stem cells in chronic myeloid leukemia.

Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples.

Disseminated infection with Prototheca zopfii after unrelated stem cell transplantation for leukemia.

Endothelial progenitor cells: a source for therapeutic vasculogenesis?

CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.

Re: Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.

Letters regarding article by Wojakowski et al, "mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction".

RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell lines.

Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case.

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

Marginal zone lymphoma of the lacrimal gland spreading to the lung and the bone marrow 11 years after first symptoms.

Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients.

CD34+/CD133- circulating endothelial precursor cells (CEP): characterization, senescence and in vivo application.

Molecular therapies for malignant glioma.

The effect of zoledronic acid on the function and differentiation of myeloid cells.

Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury.

The Dickkopf-homolog 3 is expressed in tumor endothelial cells and supports capillary formation.

[Updated strategies in Small Cell Lung Cancer post ASCO 2007].

[Small cell lung cancer].

Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation.

Increased numbers of endothelial progenitor cells in peripheral blood and tumor specimens in non-small cell lung cancer: a methodological challenge and an ongoing debate on the clinical relevance.

Dickkopf-3 as a new potential marker for neoangiogenesis in colorectal cancer: expression in cancer tissue and adjacent non-cancerous tissue.

Fludarabine/intermediate-dose cytarabine with or without allogeneic hematopoietic stem cell transplantation in poor-risk leukemia: a single center experience.

Quantification of circulating endothelial and progenitor cells: comparison of quantitative PCR and four-channel flow cytometry.

Hodgkin lymphoma in Tyrol-a population-based study.

Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.

Adenoviral-mediated endothelial precursor cell delivery of soluble CD115 suppresses human prostate cancer xenograft growth in mice.

Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo.

GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomib.

Bortezomib for the treatment of refractory Type-1 cryoglobulinaemia.

Immunohistochemically detectable dickkopf-3 expression in tumor vessels predicts survival in gastric cancer.

Increased Dkk3 protein expression in platelets and megakaryocytes of patients with myeloproliferative neoplasms.

Feasibility and toxicity of concomitant radio/immunotherapy with MabThera (Rituximab®) for patients with non-Hodkin's Lymphoma: results of a prospective phase I/II study.

"Idiopathic Bence-Jones proteinuria": a new characterization of an old entity.

Polyarteritis nodosa complicating multiple myeloma - a case report and review of the literature.

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.

New antiangiogenic strategies beyond inhibition of vascular endothelial growth factor with special focus on axon guidance molecules.

A success story: how a single targeted-therapy molecule impacted on treatment and outcome of diffuse large B-cell lymphoma.

Marine compounds inhibit growth of multiple myeloma in vitro and in vivo.

Long-term Control in a Patient with Refractory Multiple Myeloma by Oral Cyclophosphamide and Dexamethasone.